Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · IEX Real-Time Price · USD
5.90
-0.24 (-3.91%)
At close: May 17, 2024, 4:00 PM
6.06
+0.16 (2.71%)
After-hours: May 17, 2024, 7:31 PM EDT

Terns Pharmaceuticals Market Cap

Terns Pharmaceuticals has a market cap or net worth of $382.89 million as of May 17, 2024. Its market cap has decreased by -48.03% in one year.

Market Cap
382.89M
Enterprise Value
142.66M
1-Year Change
-48.03%
Ranking
Category
Stock Price
$5.90

Market Cap Chart

Since the IPO on February 5, 2021, Terns Pharmaceuticals's market cap has decreased from $406.10M to $382.89M, a decrease of -5.72%. That is a compound annual growth rate of -1.78%.

History

DateMarket Cap% Change
May 16, 2024397.10M2.50%
May 15, 2024387.40M-
May 14, 2024387.40M1.71%
May 13, 2024380.90M5.95%
May 10, 2024359.50M-5.12%
May 9, 2024378.90M-3.12%
May 8, 2024391.10M5.02%
May 7, 2024372.40M-0.51%
May 6, 2024374.30M6.43%
May 3, 2024351.70M2.84%
May 2, 2024342.00M4.14%
May 1, 2024328.40M0.58%
Apr 30, 2024326.50M-0.97%
Apr 29, 2024329.70M3.88%
Apr 26, 2024317.40M5.80%
Apr 25, 2024300.00M-2.31%
Apr 24, 2024307.10M1.29%
Apr 23, 2024303.20M-2.70%
Apr 22, 2024311.60M5.70%
Apr 19, 2024294.80M-0.67%
Apr 18, 2024296.80M1.12%
Apr 17, 2024293.50M-2.78%
Apr 16, 2024301.90M-7.70%
Apr 15, 2024327.10M-1.56%
Apr 12, 2024332.30M-1.54%
View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Organogenesis Holdings 393.74M
Esperion Therapeutics 391.96M
Tourmaline Bio 391.11M
Shattuck Labs 388.02M
Nevro 387.86M
Anika Therapeutics 386.73M
Verrica Pharmaceuticals 386.02M
Contineum Therapeutics 384.75M
Market Cap Rankings